Literature DB >> 34137929

Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma.

Xiaoliang Ma1, Xiaojun Ren2, Minhua Shen3, Fenghua Ma3, Xiaojun Chen2, Guofu Zhang4, Jinwei Qiang5.   

Abstract

OBJECTIVES: To investigate the value of volumetric ADC histogram metrics for evaluating lymphovascular space invasion (LVSI) status in stage I endometrioid adenocarcinoma (EAC).
METHODS: Preoperative MRI of 227 patients with stage I EAC were retrospectively analyzed. ADC histogram data were derived from the whole tumor with ROIs drawn on all slices of DWI scans (b = 0, 1000 s/mm2). The Student t-test was performed to compare ADC histogram metrics (minADC, maxADC, and meanADC; 10th, 25th, 50th, 75th, and 90th percentiles of ADC; skewness; and kurtosis) between the LVSI-positive and LVSI-negative groups, as well as between stage Ia and Ib EACs. ROC curve analysis was carried out to evaluate the diagnostic performance of ADC histogram metrics in predicting LVSI status in EAC.
RESULTS: The minADC and meanADC and 10th, 25th, 50th, 75th, and 90th percentiles of ADC were significantly lower in LVSI-positive EACs compared with those in the LVSI-negative groups for stage I, Ia, and Ib EACs (all p < 0.05). MeanADC ≤ 0.857 × 10-3 mm2/s, meanADC ≤ 0.854 × 10-3 mm2/s, and the 90th percentile of ADC ≤ 1.06 × 10-3 mm2/s yielded the largest AUC of 0.844, 0.844, and 0.849 for evaluating LVSI positivity in stage I, Ia, and Ib tumors, respectively, with sensitivity of 75.4%, 75.0%, and 76.2%; specificity of 80.0%, 83.1%, and 82.1%; and accuracy of 79.3%, 81.5%, and 79.6%, respectively.
CONCLUSION: Volumetric ADC histogram metrics might be helpful for the preoperative evaluation of LVSI status and personalized clinical management in patients with stage I EAC. KEY POINTS: • Volumetric ADC histogram analysis helps evaluate LVSI status preoperatively. • LVSI-positive EAC is associated with a reduction in multiple volumetric ADC histogram metrics. • MeanADC and the 90th percentile of ADC were shown to be best in evaluating LVSI- positivity in stage Ia and Ib EACs, respectively.
© 2021. European Society of Radiology.

Entities:  

Keywords:  Diffusion magnetic resonance imaging; Endometrioid adenocarcinoma; Lymphatic metastasis; Lymphatic vessels

Mesh:

Year:  2021        PMID: 34137929     DOI: 10.1007/s00330-021-07996-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.

Authors:  Justine M Briët; Harry Hollema; Nathalie Reesink; Jan G Aalders; Marian J E Mourits; Klaske A ten Hoor; Elisabeth Pras; H Marike Boezen; Ate G J van der Zee; Hans W Nijman
Journal:  Gynecol Oncol       Date:  2005-03       Impact factor: 5.482

3.  Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

Authors:  Saketh R Guntupalli; Israel Zighelboim; Nora T Kizer; Qin Zhang; Matthew A Powell; Premal H Thaker; Paul J Goodfellow; David G Mutch
Journal:  Gynecol Oncol       Date:  2011-10-26       Impact factor: 5.482

4.  Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer.

Authors:  P Lavaud; B Fedida; G Canlorbe; S Bendifallah; E Darai; I Thomassin-Naggara
Journal:  Diagn Interv Imaging       Date:  2018-02-19       Impact factor: 4.026

Review 5.  LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?

Authors:  Katherine L Harris; Kathryn A Maurer; Elke Jarboe; Theresa L Werner; David Gaffney
Journal:  Gynecol Oncol       Date:  2019-11-05       Impact factor: 5.482

6.  Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study.

Authors:  O Gemer; A Ben Arie; T Levy; M Gdalevich; M Lorian; F Barak; E Anteby; O Lavie
Journal:  Eur J Surg Oncol       Date:  2007-02-20       Impact factor: 4.424

7.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

Authors:  N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa
Journal:  Ann Oncol       Date:  2015-12-02       Impact factor: 32.976

8.  Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.

Authors:  Stavroula Kyriazi; David J Collins; Christina Messiou; Kjell Pennert; Robert L Davidson; Sharon L Giles; Stan B Kaye; Nandita M Desouza
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

9.  The role of frozen section in surgical staging of low risk endometrial cancer.

Authors:  Sanjeev Kumar; Sudeshna Bandyopadhyay; Assaad Semaan; Jay P Shah; Haider Mahdi; Robert Morris; Adnan Munkarah; Rouba Ali-Fehmi
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

10.  Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.

Authors:  Ashley E Veade; Jonathan Foote; Jessie Ehrisman; Gloria Broadwater; Brittany A Davidson; Paula S Lee; Angeles Alvarez Secord; Andrew Berchuck; Laura J Havrilesky
Journal:  World J Surg Oncol       Date:  2019-05-10       Impact factor: 2.754

View more
  1 in total

1.  Evaluation of Amide Proton Transfer-Weighted Imaging for Risk Factors in Stage I Endometrial Cancer: A Comparison With Diffusion-Weighted Imaging and Diffusion Kurtosis Imaging.

Authors:  Xingxing Jin; Ruifang Yan; Zhong Li; Gaiyun Zhang; Wenling Liu; Hongxia Wang; Meng Zhang; Jinxia Guo; Kaiyu Wang; Dongming Han
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.